KalVista Pharmaceuticals, Inc.
NASDAQ:KALV
10.69 (USD) • At close September 18, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -126.644 | -92.907 | -82.339 | -46.244 | -29.116 | -20.816 | -15.805 | -18.603 | -11.436 | -7.226 | -5.678 | -2.053 |
| Afschrijvingen & Amortisatie
| 0.816 | 0.718 | 0.564 | 0.537 | 0.512 | 0.378 | 0.18 | 0.04 | 0.033 | 0.038 | 0.027 | 0.038 |
| Uitgestelde Inkomstenbelasting
| 0 | -0.491 | 0 | -0.042 | -0.033 | 0 | 0 | 0 | 0 | 0 | 0.063 | -0.006 |
| Aandelen Gebaseerde Vergoedingen
| 21.915 | 9.922 | 11.086 | 7.118 | 4.448 | 2.966 | 1.06 | 0.394 | 0.118 | 0.036 | 0.238 | 0.047 |
| Verandering in Werkkapitaal
| 15.167 | 7.413 | -12.322 | 8.346 | -20.64 | -18.79 | 25.774 | -4.182 | -0.21 | 0.784 | 0.46 | 0.035 |
| Vorderingen
| 8.176 | -2.316 | -5.201 | 7.457 | -5.781 | -4.883 | -3.937 | -0.571 | -0 | 0 | 0 | 0 |
| Voorraden
| 0 | 2.316 | 5.201 | -7.457 | 5.781 | 4.883 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| 4.32 | 1.107 | 1.687 | 0.15 | -1.004 | 1.534 | 0.217 | -1.599 | 0.374 | 0.167 | 0.315 | -0.008 |
| Overig Werkkapitaal
| 2.671 | 6.306 | -14.009 | 8.196 | -19.636 | -20.324 | 25.557 | -2.583 | -0.584 | 0.617 | 0.145 | 0.043 |
| Overige Niet-Contante Posten
| 10.566 | 0.084 | 4.877 | 0.114 | 0.013 | -0.103 | -0.651 | -1.371 | -1.661 | 0 | 0.032 | 0.104 |
| Kasstroom uit Operationele Activiteiten
| -89.231 | -75.261 | -78.134 | -30.171 | -44.816 | -36.365 | 10.558 | -23.722 | -13.156 | -6.368 | -4.858 | -1.835 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -0.443 | -1.196 | -0.931 | -0.082 | -0.22 | -1.081 | -1.427 | -0.074 | -0.011 | -0.125 | -0.018 | -0.091 |
| Netto Overnames
| 0 | -57.86 | -57.86 | 147.654 | -16.753 | 69.422 | 0 | 34.139 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -189.231 | -98.246 | -136.92 | -201.21 | -49.797 | -79.889 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 104.955 | 140.857 | 195.711 | 53.638 | 66.77 | 11.548 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| -84.719 | 57.86 | 57.86 | -147.654 | 16.753 | -69.422 | -1.427 | 34.139 | -0.715 | 0 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| -84.719 | 41.415 | 57.86 | -147.654 | 16.753 | -69.422 | -1.427 | 34.065 | -0.011 | -0.125 | -0.018 | -0.091 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | -0.054 | -0.209 | -0.151 | 0 | -4 | 0 | -0.158 | -0.389 |
| Uitgifte van Gewone Aandelen
| 150.714 | 56.582 | 1.581 | 210.582 | 11.422 | 87.91 | 9.137 | 0.002 | 0.001 | 0.001 | 0.017 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 150.714 | 1.534 | 0.002 | 1.535 | 0.216 | 0.242 | 0.009 | 0 | 33.002 | 8.661 | 6.556 | 5.953 |
| Kasstroom uit Financieringsactiviteiten
| 150.714 | 58.116 | 1.581 | 212.117 | 11.584 | 87.943 | 8.986 | 0.002 | 33.003 | 8.662 | 6.415 | 5.564 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| -1.213 | 1.236 | -1.167 | 0.511 | 0.262 | -1.205 | 1.988 | -1.159 | -0.598 | -0.124 | 0 | 0 |
| Netto Kasstroomverandering
| -24.449 | 25.506 | -19.86 | 34.803 | -16.217 | -19.049 | 20.105 | 9.186 | 19.238 | 2.045 | 1.539 | 3.638 |
| Kaspositie aan het Einde van de Periode
| 31.789 | 56.238 | 30.732 | 50.592 | 15.789 | 32.006 | 51.055 | 30.95 | 21.764 | 2.526 | 9.781 | 8.242 |